Trial intelligence / Profile preview

Cardiovascular Safety of Xenon in General Anaesthesia

NCT01120405Phase 3Completed

Sponsor
Air Liquide
Start
May 2010
Primary completion
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of xenon, sponsored by Air Liquide. Started May 2010; status: completed.

02

Drugs

xenon

Beyond the preview

Go deeper on NCT01120405.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01120405.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call